Stock·NASDAQ·Technology
Arm Holdings (ARM)
- Market cap
- $194.19B
- P/E
- 208.61
- Dividend yield
- No dividend
- Street target
- $270.00median of 43 analysts
- 52-week range
- $100.02 $452.70
ARM stock forecast today
Where ARM stands today, and what CleaRank Financial AI makes of it.
ARM at a glance
Arm Holdings (ARM): Hold, 41/100 on CleaRank's AI score.
- Trend Mixed: the price is below both its 50- and 200-day moving averages, though the 50-day is still above the 200-day ($250.52 and $231.52).
- Earnings ARM beat estimates in 6 of the 7 reports in our data, yet fell in the first session after 4 of those beats.
- Insiders Insiders sold $72.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 208.6 against 35.1 for the Technology sector: a premium to peers (+494%).
Figures as of November 10, 2026.
CleaRank Financial AI
CleaRank rates Arm Holdings (ARM) Hold, with a model score of 41/100.
The analysts' outlook lifts the score most: 28 of 43 analysts rate it a buy and the median target is 48.8% above the price. The trend holds it back most: the price is 21.61% below its 200-day average and 27.55% below its 50-day average. The 50-day average stands at $250.52 and the 200-day at $231.52. Over the past year the price rose 17.21%.
Only on CleaRank
Figures we compute ourselves from ARM's own price, earnings and insider-filing history. Tap one to see it in context.
ARM stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price below its 50-day average ›
The price of $181.49 is 27.6% below the 50-day simple moving average of $250.52.Price below its 200-day average ›
The price is 21.6% below the 200-day simple moving average of $231.52.50-day average above the 200-day ›
The 50-day average ($250.52) is 8.2% above the 200-day average ($231.52), the arrangement of a rising longer-term trend.In the lower half of its 52-week range ›
The price sits at 23% of its 52-week range, between $100.02 and $452.70.
ARM share price
Pick a period: each tab shows how far ARM has moved over it, to the last close.
Today's trading
Where ARM sits inside today's range and its 52-week range.
ARM fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E above the sector median ›
The trailing P/E of 208.61 is 494.3% above the Technology median of 35.1.P/S above the sector median ›
The price-to-sales ratio of 35.54 is 367.6% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $936.0M on revenue of $5.5B, a net margin of 17.1%.Beat estimates in most recent reports ›
ARM beat the EPS estimate in 6 of the 7 reports in our data.
Key statistics
The headline figures for ARM.
As of November 10, 2026, ARM trades at $181.49, with a market value of $194.19B and a P/E ratio of 208.61.
What the numbers say
CleaRank Financial AI's reading of ARM's valuation, growth and risks.
Against the 35.1 median P/E of Technology stocks, ARM's P/E of 208.61 is 494.3% above that median, which counts as a premium to peers. ARM has a market capitalisation of $194.2B and trailing earnings of $0.87 a share.
The company keeps a net margin of 17.13% and an operating margin of 13.93%. Return on equity stands at 11.35%, which is below the sector median of 13.4%. Debt-to-equity is 0.06.
In its most recent report, on November 4, 2026, ARM reported EPS of $0.52. That result beat the analysts' figure by 8.33%. The stock still fell 13.08% in the first session to trade on it.
ARM has beaten the EPS estimate in 6 of the 7 reports in our data, yet those beats have not reliably lifted the shares: the stock dropped in the first session after 4 of them. Among the 3 reports before the latest, the biggest reaction followed the May 6, 2026 report. That quarter beat the estimate by 3.45%, but the stock fell 10.11%.
ARM's daily returns have a 30-day standard deviation of 4.85%, and its beta against the S&P 500 is 3.94. A P/E of 208.61 sits 494.3% above the sector median, so the stock is at a premium to peers and any weak result would be judged against a high bar. The trend also works against holders until the price climbs back above its moving averages. At 59.91% below its 52-week high of $452.70, the stock has a long way to recover.
ARM against the Technology sector
How ARM compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: ARM trades at a significant premium to sector peers (+494% against the sector median P/E). Investors are paying more for each dollar of earnings than for the typical stock in the sector.
Return vs XLK: Since May 30, 2025, ARM has gained 45.7% against a gain of 46.3% for XLK.
Performance against XLK
ARM and the Technology sector fund over the same days.
Revenue and earnings
How much ARM sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); ARM reported again on November 4, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 22.8% in FY2026 to $4.9B, from $4.0B a year earlier.
Profit margin: The net margin was 18.4% in FY2026, down from 19.8% the year before.
Profitable: ARM earned $904M in FY2026.
Earnings reality check
Did ARM beat what analysts expected, and how did the stock react?
Earnings record: ARM beat the analyst estimate in 6 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Nov 4, 2026 | $0.48 | $0.52 | +8.33% | -13.08% | - |
| Jul 29, 2026 | $0.40 | $0.45 | +12.50% | +7.40% | +22.10% |
| May 6, 2026 | $0.58 | $0.60 | +3.45% | -10.11% | -6.78% |
| Feb 4, 2026 | $0.41 | $0.43 | +4.88% | +5.70% | +19.43% |
| Jul 30, 2025 | $0.35 | $0.35 | +0.00% | -13.44% | -16.66% |
| May 7, 2025 | $0.52 | $0.55 | +5.77% | -6.18% | +7.46% |
| Feb 5, 2025 | $0.34 | $0.39 | +14.71% | -3.34% | -10.30% |
As of November 10, 2026, ARM has beaten the analyst EPS estimate in 6 of the 7 reports in our data and fell in the first trading session after 4 of those beats; its latest report, on November 4, 2026, came in 8.33% above the estimate and the stock moved -13.08% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
ARM AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 35.3, showing bearish momentum without being oversold.RSI below 50 ›
An RSI of 35.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of ARM
The score, the reasoning behind it, and what could move the price next.
Arm Holdings (ARM) has been trending down. The price of $181.49 sits 27.55% below its 50-day average of $250.52 and 21.61% below its 200-day average of $231.52. It is also near the floor of its 52-week range: 81.45% above the low of $100.02, yet 59.91% below the high of $452.70. The 50-day average is 8.21% above the 200-day, so the longer average has not yet adjusted to the weaker price.
A recent pullback sits inside a stronger longer record: the price fell 31.84% over the past month, fell 32.51% over the past three months and rose 17.21% over the past year. The 14-day RSI of 35.3 is in the bearish zone, above the oversold line, and the MACD line is negative. Volume in the last session ran 40.0% below its average, on a day the price fell 2.58%.
Rating reaffirmed ›
UBS kept its Buy rating on November 6, 2026.
Source: Analyst action, UBS, November 6, 2026
Earnings beat, but the stock fell ›
The November 4, 2026 report beat the EPS estimate by 8.33%, and the share price fell 13.08% in the first session after it.
Source: Earnings report, November 4, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $211.52 above the price, and the 52-week low at $100.02 below it.
- With the 14-day RSI at 35.3, momentum reads as bearish, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum in either direction.
- Following the November 4, 2026 report, the share price dropped 13.08% in the first session. Over the 7 reports in our data, ARM has beaten estimates in 6.
ARM sits below its 50-day and 200-day moving averages ($250.52 and $231.52), and that is why the trend is down. A recovery would begin with a move back above the 200-day average. The first level overhead is the 20-day EMA, at $211.52.
Arm Holdings (ARM) has the 52-week low of $100.02 as its next level below the price. With the RSI in the bearish zone, momentum still leans toward that level.
Technical indicators
Momentum and trend for ARM, from its daily closes.
As of November 10, 2026, with ARM at $181.49, its 14-day RSI is 35.3 (showing bearish momentum without being oversold), its 50-day simple moving average is $250.52 and its 200-day is $231.52.
Calculated by CleaRank on daily closes as of November 10, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ARM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 10, 2026, ARM's 1-year correlation of daily returns is +0.61 with S&P 500 (SPY), +0.70 with Nasdaq 100 (QQQ), +0.23 with Bitcoin (BTC) and +0.15 with gold (XAU).
ARM price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
28 of 43 analysts rate it a buy or strong buy, 14 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $270.00 is 48.8% above the price.Larger share of buy ratings than three months ago ›
28 of 43 rate it a buy now, against 27 of 42 three months ago.
ARM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 6, 2026 | UBS | Maintains | Buy |
| Nov 5, 2026 | UBS | Maintains | Buy |
| Nov 5, 2026 | JP Morgan | Maintains | Overweight |
| Nov 5, 2026 | TD Cowen | Maintains | Buy |
| Nov 5, 2026 | RBC Capital | Maintains | Outperform |
| Nov 5, 2026 | Barclays | Maintains | Overweight |
As of November 10, 2026, 43 Wall Street analysts cover ARM: 28 rate it a buy or strong buy, 14 a hold and 1 a sell or strong sell. Their 12-month price targets range from $125.00 to $500.00. The median ARM price target is $270.00, 48.8% above the price of $181.49.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ARM risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much ARM tends to move, against the market and on its own.
ARM price history and drawdowns
ARM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Typical daily move of 2% or more ›
A typical daily move is 4.85% (the standard deviation of the last 30 daily returns).Not yet recovered from its worst fall ›
The worst fall was 62.1%, from June 2026 to November 2026; the price is still 58.7% below that peak.Most 1-year holds ended higher ›
71% of 1-year holding periods in the last 3 years ended with a gain.Beat the S&P 500 since October 2023 ›
$10,000 invested in October 2023 is now worth $34,728, against $18,196 in the S&P 500 (SPY).
ARM Drawdowns & Recovery
As of November 10, 2026, ARM's worst peak-to-trough fall over the last 3 years was -62.1% (June 2026 to November 2026); it is still 58.7% below that peak, and 71% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ARM in October 2023 is worth now, against the same amount in the S&P 500.
Against the market: ARM beat the S&P 500 over this period: $34,728 against $18,196.
A $10,000 investment in ARM in October 2023 would be worth about $34,728 today, compared with about $18,196 for the same investment in the S&P 500 benchmark with its dividends reinvested.
Seasonal patterns
Which calendar months have been kind to ARM, and which have not.
Strongest month, February: an average of +36.92%, up in 2 of 3 years.
Weakest month, August: an average of -12.05%, up in 0 of 3 years.
This month, November: has averaged -0.56%, up in 1 of 3 years. Past seasonality does not repeat on schedule.
Across 3 calendar years of history, ARM's strongest calendar month has been February (average +36.92%, up in 2 of 3 years) and its weakest August (average -12.05%, up in 0 of 3 years).
Average return for each calendar month across 3 calendar years of history, from weekly closing prices.
ARM stock price prediction 2029
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ARM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 3-year Monte Carlo simulation, based on 3.1 years of price history, projects that a $10,000 investment in ARM today could grow to about $13,736 by 2029 in the base case, with a 90th-percentile outcome near $41,676 and a 10th-percentile outcome around $4,527. Projections are statistical simulations, not guarantees.
ARM Stock Price Prediction 2029: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $249 for ARM by 2029 in the base case, from $181 today (1.4x over 3 years). The 10th-percentile path ends near $82.17. These are outcomes of a Monte Carlo simulation run on ARM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $106 | $202 | $383 | |
| 2028 | $90.61 | $224 | $555 | |
| 2029 | $82.17 | $249 | $756 |
Method: a lognormal simulation of ARM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
ARM insider trading
What the people running the company have bought and sold.
ARM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought ARM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 10, 2026, ARM insiders reported 19 open-market sales worth $72.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 10.4K | $3.1M |
| Aug 31, 2026 | Rene A Haas
Chief Executive Officer
|
Grant | 64 | $15.5K |
| Aug 27, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 10.4K | $2.7M |
| Aug 17, 2026 | Laura Kathleen Bartels
Officer
|
Grant | 1.7K | - |
| Aug 7, 2026 | Jeffrey A. Sine
Director
|
Grant | 9.6K | - |
| Jun 2, 2026 | Laura Kathleen Bartels
Officer
|
Sell | 11.3K | $4.4M |
| Jun 1, 2026 | William Abbey
Officer
|
Sell | 6.6K | $2.6M |
| May 28, 2026 | William Abbey
Officer
|
Sell | 4.2K | $1.4M |
| May 22, 2026 | William Abbey
Officer
|
Sell | 2.3K | $703.4K |
| May 21, 2026 | Charlotte Claire Eaton
Officer
|
Sell | 7.8K | $2.3M |
| May 21, 2026 | Charlotte Claire Eaton
Officer
|
Sell | 7.1K | $1.9M |
| May 21, 2026 | William Abbey
Officer
|
Sell | 4.7K | $1.3M |
| May 20, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 31.9K | $7.2M |
| May 20, 2026 | William Abbey
Officer
|
Sell | 16.0K | $3.7M |
| May 19, 2026 | Spencer Collins
Officer
|
Sell | 40.9K | $8.8M |
| May 18, 2026 | Richard Roy Grisenthwaite
Officer
|
Sell | 24.3K | $5.1M |
| May 15, 2026 | William Abbey
Officer
|
Sell | 10.2K | $2.2M |
| May 15, 2026 | William Abbey
Officer
|
Grant | 23.3K | - |
| May 15, 2026 | William Abbey
Officer
|
Grant | 8.2K | - |
| May 15, 2026 | Laura Kathleen Bartels
Officer
|
Grant | 6.8K | - |
| May 15, 2026 | Jason E Child
Chief Financial Officer
|
Grant | 81.4K | - |
| May 15, 2026 | Jason E Child
Chief Financial Officer
|
Grant | 9.3K | - |
| May 15, 2026 | Spencer Collins
Officer
|
Grant | 69.1K | - |
| May 15, 2026 | Spencer Collins
Officer
|
Grant | 8.1K | - |
| May 15, 2026 | Charlotte Claire Eaton
Officer
|
Grant | 5.6K | - |
| May 15, 2026 | Charlotte Claire Eaton
Officer
|
Grant | 2.2K | - |
| May 15, 2026 | Richard Roy Grisenthwaite
Officer
|
Grant | 22.6K | - |
| May 15, 2026 | Richard Roy Grisenthwaite
Officer
|
Grant | 22.7K | - |
| May 15, 2026 | Rene A Haas
Chief Executive Officer
|
Grant | 265.6K | - |
| May 15, 2026 | Paul E Jacobs
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Rosemary M Schooler
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Jeffrey A. Sine
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Young K Sohn
Director
|
Grant | 2.1K | - |
| May 11, 2026 | Spencer Collins
Officer
|
Sell | 52.0K | $11.0M |
| Apr 22, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 21.3K | $3.8M |
| Apr 14, 2026 | Rene A Haas
Chief Executive Officer
|
Sell | 9.3K | $1.5M |
| Mar 26, 2026 | Rene A Haas
Chief Executive Officer
|
Sell | 31.9K | $5.1M |
| Mar 25, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 21.3K | $3.2M |
Source: TwelveData, from reported insider filings
ARM stock forecast: questions people ask
Answered from the figures on this page, as of November 10, 2026.